U.S. technology entrepreneur Bryan Johnson is questioning whether he may have taken his pursuit of longevity too far, weeks after being diagnosed with an autoimmune condition that affects his stomach.
Johnson, known for his highly regimented approach to extending human lifespan, raised the question in a recent discussion about his health and longevity efforts. His comments come after he revealed that he had been diagnosed with autoimmune gastritis.
The diagnosis has prompted Johnson to reconsider some aspects of the health experiment that has made him a prominent figure in the longevity movement.
For years, Johnson has followed an intensive regimen involving strict dietary practices, exercise, sleep monitoring and regular health testing. His approach has attracted significant attention online, with supporters viewing his efforts as an experiment in extending healthy human life and critics questioning the sustainability and scientific basis of some of his methods.
Johnson’s recent comments add a more personal dimension to the debate surrounding extreme longevity protocols. Rather than presenting his regimen as an established path to longer life, he appears to be reflecting on whether his efforts to optimise his health may have gone beyond what was appropriate for his body.
The entrepreneur previously said that his autoimmune gastritis diagnosis was confirmed in May after years of persistently low ferritin levels that did not improve despite dietary changes and iron supplements, according to reports.
READ: 6,600 noncitizens wrongly registered to vote in New Jersey after DMV software error (July 22, 2026)
Autoimmune gastritis is a condition in which the immune system attacks cells in the stomach lining. The condition can affect the body’s ability to absorb certain nutrients and may be difficult to identify in its early stages.
Johnson’s experience highlights a broader question surrounding the growing popularity of longevity science and extreme health optimisation. As wealthy entrepreneurs and technology figures invest in personalised health monitoring, supplements, dietary interventions and experimental approaches, questions remain about the long-term benefits and risks of such regimens.
The pursuit of longer life has also become increasingly commercialised, with a growing industry offering consumers access to genetic testing, biomarker tracking, personalised nutrition and other interventions marketed around healthy aging.
Johnson has positioned himself as one of the most visible advocates of this movement. His Blueprint program, which focuses on tracking and attempting to optimise various measures of health and aging, has attracted a global online following.
His latest comments, however, suggest that even advocates of aggressive longevity strategies may face unexpected health challenges.
The diagnosis does not establish that Johnson’s longevity regimen caused his autoimmune condition. Instead, Johnson’s comments raise a broader question about the limits of efforts to control the aging process through intensive lifestyle and health interventions.
His experience also illustrates the difficulty of separating personal experimentation from established medical evidence. While some components of Johnson’s routine, such as exercise, sleep and a balanced diet, are broadly associated with health benefits, the effects of more intensive or unconventional longevity practices can vary and require careful scientific evaluation.
READ: Viral Saipan birth tourism video resurfaces as Trump targets birthright citizenship (July 10, 2026)
For Johnson, the autoimmune diagnosis appears to have prompted a period of reassessment. His public reflection on whether he went too far could add another dimension to the ongoing debate over how far people should go in pursuit of longer and healthier lives.
The entrepreneur’s story is likely to continue attracting attention as interest in longevity research grows, particularly among technology leaders and wealthy individuals seeking to use emerging science to extend human healthspan.
For now, Johnson’s experience serves as a reminder that the pursuit of longevity remains an evolving field, and that efforts to optimise health do not eliminate the uncertainty and complexity of human biology.